Avon Whitening Essentials

Description

AVON Whitening Essentials Fluoride Toothpaste is formulated to provide cavity protection while assisting in the whitening of teeth by removing surface stains. The toothpaste contains activated charcoal, which contributes to its whitening properties. It is available in a fresh mint flavor, enhancing the overall user experience. The product is packaged in a net weight of 0.7 oz (20 g).

Uses and Indications

This drug is indicated for the protection against cavities.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Adults and children aged 6 years and older are advised to brush their teeth thoroughly after each meal or at least twice daily, or as directed by a dentist or physician. It is important to ensure that the product is not swallowed.

For children between the ages of 6 and 12 years, a pea-sized amount of the product should be used to minimize the risk of swallowing. Caregivers should supervise the brushing and rinsing process until proper oral hygiene habits are established.

For children under the age of 6 years, it is recommended to consult a dentist or physician for appropriate guidance on usage.

Contraindications

The product should not be swallowed. In the event that more than the recommended amount for brushing is accidentally ingested, seek medical assistance or contact a Poison Control Center immediately. Discontinue use immediately if an allergic reaction occurs.

Warnings and Precautions

It is imperative to keep this product out of reach of children under 6 years of age to prevent accidental ingestion. In the event that more than the recommended amount for brushing is swallowed, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Healthcare professionals should be vigilant for signs of allergic reactions. Should any allergic response occur, the use of the product must be discontinued immediately to mitigate potential adverse effects.

Side Effects

Patients may experience adverse reactions during treatment. In the event of an allergic reaction, it is imperative to discontinue use immediately.

No additional serious or common adverse reactions have been specified in the available data. It is essential for healthcare providers to monitor patients for any signs of adverse effects and to take appropriate action if an allergic reaction occurs.

Drug Interactions

There are no documented drug interactions associated with this medication. Additionally, there are no reported interactions between this drug and laboratory tests. Therefore, no specific dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Avon Whitening Essentials (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be kept out of reach of children under 6 years of age. For children between 6 and 12 years, it is recommended to use a pea-sized amount to minimize swallowing, and caregivers should supervise brushing and rinsing until proper oral hygiene habits are established. For children under 6 years, consultation with a dentist or physician is advised. In case of accidental swallowing of more than the amount used for brushing, medical help or contact with a Poison Control Center should be sought immediately.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment and the need to inform their healthcare provider if they become pregnant or plan to become pregnant while on this medication.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific concerns have been identified in the available information.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, it is critical to seek immediate medical assistance or contact a Poison Control Center if an amount exceeding that typically used for brushing is accidentally ingested.

Healthcare professionals should be aware that prompt intervention is essential in managing potential overdosage scenarios. Symptoms may vary depending on the specific substance involved, and monitoring for adverse effects is recommended.

Management procedures should include supportive care and symptomatic treatment as necessary. It is advisable to have the product's labeling and any relevant patient information readily available when contacting medical professionals or poison control for guidance.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children under 6 years of age to prevent accidental ingestion. It is important to instruct patients not to swallow the product during use. In the event that more than the recommended amount for brushing is accidentally swallowed, patients should seek medical help or contact a Poison Control Center immediately.

Additionally, healthcare providers should inform patients to discontinue use of the product immediately if they experience any signs of an allergic reaction. This proactive communication can help ensure patient safety and promote appropriate use of the product.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature, ensuring that it is protected from light exposure to maintain its integrity. Freezing the product is strictly prohibited, as it may compromise its effectiveness. Additionally, once opened, the product must be discarded to ensure safety and efficacy.

Additional Clinical Information

The route of administration for the product is dental. Clinicians should advise patients to keep the product out of reach of children, particularly those under 6 years of age. It is important to instruct patients not to swallow the product. In the event that more than the recommended amount is accidentally ingested, patients should seek medical assistance or contact a Poison Control Center immediately. Additionally, if any allergic reactions occur, patients should discontinue use immediately.

Drug Information (PDF)

This file contains official product information for Avon Whitening Essentials, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)